International Inclusion Body Myositis (IBM) Genetics Consortium reaches 750 samples

The International muscle consortium led by the UCL Institute of Neurology reaches 750 Inclusion Body Myositis (IBM) patients, and aims for 1,000 patients to donate a blood sample for a groundbreaking genome wide study to understand the disease pathways in this disorder and accelerate therapeutics.